Effects of Testosterone Treatment in Older Men
Peter J. Snyder,Shalender Bhasin,Glenn R. Cunningham,Alvin M. Matsumoto,Alisa J. Stephens-Shields,J. A. Cauley,Thomas M. Gill,Elizabeth Barrett-Connor,Ronald S. Swerdloff,Ronald S. Swerdloff,Christina Wang,Christina Wang,Kristine E. Ensrud,Cora E. Lewis,John T. Farrar,David Cella,Raymond C. Rosen,Marco Pahor,Jill P. Crandall,Mark E. Molitch,Denise Cifelli,Darlene Dougar,Laura Fluharty,Susan M. Resnick,Thomas W. Storer,Stephen D. Anton,Shehzad Basaria,Susan J. Diem,X. Hou,Emile R. Mohler,J. K. Parsons,Nanette K. Wenger,Bret Zeldow,J. R. Landis,Susan S. Ellenberg +34 more
Reads0
Chats0
TLDR
In symptomatic men 65 years of age or older, raising testosterone concentrations for 1 year from moderately low to the mid-normal range for men 19 to 40 years ofAge had a moderate benefit with respect to sexual function and some benefit withrespect to mood and depressive symptoms but no benefit with Respect to vitality or walking distance.Abstract:
BackgroundSerum testosterone concentrations decrease as men age, but benefits of raising testosterone levels in older men have not been established. MethodsWe assigned 790 men 65 years of age or older with a serum testosterone concentration of less than 275 ng per deciliter and symptoms suggesting hypoandrogenism to receive either testosterone gel or placebo gel for 1 year. Each man participated in one or more of three trials — the Sexual Function Trial, the Physical Function Trial, and the Vitality Trial. The primary outcome of each of the individual trials was also evaluated in all participants. ResultsTestosterone treatment increased serum testosterone levels to the mid-normal range for men 19 to 40 years of age. The increase in testosterone levels was associated with significantly increased sexual activity, as assessed by the Psychosexual Daily Questionnaire (P<0.001), as well as significantly increased sexual desire and erectile function. The percentage of men who had an increase of at least 50 m in ...read more
Citations
More filters
Journal ArticleDOI
Clinical practice guidelines in oncology
William J. Gradishar,Benjamin O. Anderson,Ron Balassanian,Sarah L. Blair,Harold J. Burstein,Amy E. Cyr,Anthony D. Elias,William B. Farrar,Andres Forero,Sharon H. Giordano,Matthew P. Goetz,Lori J. Goldstein,Steven J. Isakoff,Janice A. Lyons,P. Kelly Marcom,Ingrid A. Mayer,Beryl McCormick,Meena S. Moran,Ruth O'Regan,Sameer A. Patel,Lori J. Pierce,Elizabeth C. Reed,Kilian E. Salerno,Lee S. Schwartzberg,Amy Sitapati,Karen L. Smith,Mary Lou Smith,Hatem Soliman,George Somlo,Melinda L. Telli,John H. Ward,Rashmi Kumar,Dorothy A. Shead +32 more
TL;DR: This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.
Journal ArticleDOI
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
Shalender Bhasin,Juan P. Brito,Glenn R. Cunningham,Frances J. Hayes,Howard N. Hodis,Alvin M. Matsumoto,Peter J. Snyder,Ronald S. Swerdloff,Frederick C. W. Wu,Maria A Yialamas +9 more
TL;DR: It is suggested that when clinicians institute T therapy, they aim at achieving T concentrations in the mid-normal range during treatment with any of the approved formulations, taking into consideration patient preference, pharmacokinetics, formulation-specific adverse effects, treatment burden, and cost.
Journal ArticleDOI
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.
TL;DR: The evolution, controversies and challenges in defining sarcopenic obesity are discussed, and current body composition modalities used to assess this condition are presented and current treatment strategies are outlined.
Journal ArticleDOI
Welcome to the ICD-10 code for sarcopenia.
TL;DR: The new ICD‐10‐CM (M62.84) code for sarc Openia represents a major step forward in recognizing sarcopenia as a disease and should lead to an increase in availability of diagnostic tools and the enthusiasm for pharmacological companies to develop drugs for sarc openia.
Journal ArticleDOI
Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline
Maria Fleseriu,Ibrahim A. Hashim,Niki Karavitaki,Niki Karavitaki,Shlomo Melmed,M. Hassan Murad,Roberto Salvatori,Mary H. Samuels +7 more
TL;DR: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacements or under-replacement, and managing hypopitsuits during pregnancy, pituitary surgery, and other types of surgeries.
References
More filters
Journal ArticleDOI
Development and validation of brief measures of positive and negative affect: The PANAS scales.
TL;DR: Two 10-item mood scales that comprise the Positive and Negative Affect Schedule (PANAS) are developed and are shown to be highly internally consistent, largely uncorrelated, and stable at appropriate levels over a 2-month time period.
Journal ArticleDOI
The PHQ-9: validity of a brief depression severity measure.
TL;DR: In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.
Book
SF-36 health survey: Manual and interpretation guide
TL;DR: TheSF-36 is a generic health status measure which has gained popularity as a measure of outcome in a wide variety of patient groups and social and the contribution of baseline health, sociodemographic and work-related factors to the SF-36 Health Survey: manual and interpretation guide is tested.
Journal ArticleDOI
More powerful procedures for multiple significance testing.
Yosef Hochberg,Yoav Benjamini +1 more
TL;DR: Some new, general and simple procedures are discussed and demonstrated by two examples from the medical literature: the neuropsychologic effects of unidentified childhood exposure to lead, and the sleep patterns of sober chronic alcoholics.
Journal ArticleDOI
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
TL;DR: Observations of health factor independent, age-related longitudinal decreases in T and free T, resulting in a high frequency of hypogonadal values, suggest that further investigation of T replacement in aged men, perhaps targeted to those with the lowest serum T concentrations, are justified.
Related Papers (5)
Adverse Events Associated with Testosterone Administration
Shehzad Basaria,Andrea D. Coviello,Thomas G. Travison,Thomas W. Storer,Wildon Farwell,Wildon Farwell,Alan M. Jette,Richard Eder,Sharon L. Tennstedt,Jagadish Ulloor,Anqi Zhang,Karen Choong,Kishore M. Lakshman,Norman A. Mazer,Renee Miciek,Joanne B. Krasnoff,Ayan Elmi,Philip E. Knapp,Brad Brooks,Erica R. Appleman,Sheetal Aggarwal,Geeta Bhasin,Leif Hede-Brierley,Ashmeet Bhatia,Lauren Collins,Nathan K. LeBrasseur,Louis D. Fiore,Shalender Bhasin +27 more
Identification of late-onset hypogonadism in middle-aged and elderly men.
Frederick C. W. Wu,Abdelouahid Tajar,Jennifer M. Beynon,Stephen R Pye,Alan J. Silman,Joseph D. Finn,Terence W O'Neill,Gyorgy Bartfai,Felipe F. Casanueva,Gianni Forti,Aleksander Giwercman,Thang S. Han,Krzysztof Kula,Michael E. J. Lean,Neil Pendleton,Margus Punab,Steven Boonen,Dirk Vanderschueren,Fernand Labrie,Ilpo Huhtaniemi +19 more